Research Funding

AHRQ Grants for Health Services Research Dissertation Program

R36 Dissertation Award
PA-15-318
Application Due Dates:  November 1, 2015; February 1, 2016; May 1, 2016; August 1, 2016; November 1, 2016

Research Objectives

Applications for dissertation research grants must be responsive to AHRQ’s mission, which is to produce evidence to make health care safer, higher quality, more accessible, equitable and affordable, and to work within HHS and with other partners to make sure that the evidence is understood and used.  Within the mission, AHRQ’s specific priority areas of focus are:

  • Improve health care quality by accelerating implementation of Patient Centered Outcomes Research (PCOR)
  • Make health care safer
  • Increase accessibility by evaluating expansions of insurance coverage
  • Improve health care affordability, efficiency and cost transparency

AHRQ research priority areas are described at http://www.ahrq.gov/funding/policies/foaguidance/index.html.

Applicants are strongly encouraged to focus on topical areas unique to AHRQ, demonstrating how expected results can be used or made available for use to enhance healthcare quality. Results should be directly relevant to customers, such as providers and practitioners, administrators, payers, consumers, policymakers, and insurers.

Candidates are encouraged to address health services research issues critical to AHRQ priority populations, including: individuals living in inner city or rural (including frontier) areas; low-income and minority groups; women, children, the elderly; and individuals with special health care needs, including those with disabilities and those who need chronic or end-of-life health care.

Candidates must conduct dissertation projects which focus on health care delivery in the United States. AHRQ will not accept international health care research projects.

– See more at: http://grants.nih.gov/grants/guide/pa-files/PA-15-318.html

FY15 Peer Reviewed Cancer Research Program RFA

The FY15 Defense Appropriations Act provides $50 million (M) to the Department of Defense Peer Reviewed Cancer Research Program (PRCRP) to support innovative, high-impact cancer research.  As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate manages and executes the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation.  The executing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).

FY15 PRCRP Program Announcement and General Application Instructions for the following award mechanism are posted on the Grants.gov website.
Congressionally Directed Topic Areas:  To be considered for funding, applications for the FY15 PRCRP must address at least one of the Topic Areas as directed by Congress.  Research applications in the areas of breast, prostate, lung (excluding mesothelioma), or ovarian cancer will not be accepted.  The FY15 PRCRP Topic Areas are listed below:

  • Colorectal cancer
  • Genetic cancer
  • Kidney cancer
  • Listeria vaccine for cancer
  • Liver cancer (New for FY15)
  • Melanoma and other skin cancers
  • Mesothelioma
  • Myeloproliferative disorders
  • Neuroblastoma
  • Pancreatic cancer
  • Stomach cancer (New for FY15)

To address the cancer health needs of both deployed and non-deployed personnel, their dependents, retirees, and Veterans, the FY15 PRCRP encourages studies that are responsive to the FY15 Military Relevance Focus Areas listed below:

  • Militarily relevant risk factors associated with cancer (e.g., ionizing radiation, chemicals, infectious agents, and environmental carcinogens).
  • Gaps in cancer prevention, screening, early detection, diagnosis, treatment, and/or survivorship that may affect the general population but have a particularly profound impact on the health and well-being of military members, Veterans, and their beneficiaries.

Horizon Award – Letter of Intent due August 11, 2015

PI:  Both pre-doctoral candidates and postdoctoral fellows are eligible.

Mentor:  The Mentor must be an experienced cancer researcher as demonstrated by a strong record of funding and publications.  In addition, the Mentor must demonstrate a commitment to advancing the PI’s career in cancer research.

The PI and the Mentor must be at the same organization

  • Letter of Intent is required.
  • Supports junior level scientists to conduct impactful research with the mentorship of an experienced cancer researcher (i.e., Mentor)
  • Challenges junior scientists to develop and implement research in the cancer field
  • Emphasis on discovery
  • Must address at least one of the FY15 PRCRP Topic Areas
  • Encouraged to address at least one of the FY15 PRCRP Military Relevance Focus Areas
  • Preliminary data are not required

Clinical trials are not allowed

    • Maximum funding for the entire period of performance is $75,000 for direct costs (plus indirect costs)

Maximum period of performance is 1 year

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final Program Announcements and General Application Instructions that are available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.

Applications must be submitted through the federal government’s single-entry portal, Grants.gov.  Submission deadlines are not available until the Program Announcements are released.  Requests for email notification of the Program Announcements release may be sent to help@ebrap.org.  For more information about the PRCRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).

Point of Contact:
CDMRP Help Desk 301-6682-5507 help@rebrap.org

AUR Research and Education Foundation Seeking Applications for Ethics and Professionalism Grants for Radiologists

Deadline:  January 10, 2015

The goals of the AUR Research and Education Foundation, the charitable arm of the Association of University Radiologists are to encourage excellence in radiological laboratory and clinical investigation, teaching and clinical practice; to stimulate an interest in academic radiology as a medical career; to advance radiology as a medical science; and to represent academic radiology at a national level.

The foundation is currently accepting applications its Ethics and Professionalism in Radiology Project Grants, which are designed to improve patient care and safety, and to promote social responsibility in medical care and practice by providing funding opportunities for the study and teaching of ethics and professionalism in radiology.

Projects that address any aspect of ethics and professionalism in radiology will be considered. Examples of types of projects include, but are not limited to, research of ethical dilemmas faced by academic radiologists or radiology physicians-in-training and the methods by which the dilemmas are addressed and educational programs to teach ethics and professionalism to practicing radiologists, to radiology physicians-in-training, or to allied members of the academic radiology community.

Grants of up to $50,000 will be awarded in a single year. The awards may be used for salary support and/or other project costs. Through this grant program, the AUR Research & Education Foundation does not pay institutional indirect costs or overhead costs, or tuition.

Any member of AUR is eligible to apply as principal investigator. However, it is not necessary for all members of the research or development team to be AUR members.  Eligibility of the principal investigator must be maintained throughout the grant period.

See the AUR website for complete program guidelines and application instructions.